Cerner Co. (NASDAQ:CERN) President Zane M. Burke sold 50,000 shares of the business’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $70.00, for a total value of $3,500,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Shares of Cerner Co. (NASDAQ CERN) opened at $69.42 on Friday. Cerner Co. has a 12-month low of $47.09 and a 12-month high of $73.86. The firm has a market capitalization of $23,080.00, a PE ratio of 30.82, a price-to-earnings-growth ratio of 2.25 and a beta of 0.94. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.77 and a quick ratio of 2.75.
Cerner (NASDAQ:CERN) last announced its quarterly earnings results on Thursday, October 26th. The company reported $0.61 earnings per share for the quarter, missing analysts’ consensus estimates of $0.62 by ($0.01). Cerner had a return on equity of 18.03% and a net margin of 13.37%. The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same period in the prior year, the firm earned $0.59 EPS. Cerner’s quarterly revenue was up 7.7% on a year-over-year basis. sell-side analysts expect that Cerner Co. will post 2.25 EPS for the current fiscal year.
CERN has been the topic of a number of recent research reports. Cantor Fitzgerald restated a “buy” rating and issued a $77.00 target price on shares of Cerner in a research note on Tuesday, October 10th. KeyCorp restated a “buy” rating and issued a $76.00 target price on shares of Cerner in a research note on Friday, September 22nd. Robert W. Baird restated a “hold” rating and issued a $67.00 target price on shares of Cerner in a research note on Thursday, August 31st. SunTrust Banks restated a “buy” rating and issued a $79.00 target price on shares of Cerner in a research note on Thursday, October 19th. Finally, Zacks Investment Research downgraded Cerner from a “hold” rating to a “sell” rating in a research note on Tuesday, September 26th. One analyst has rated the stock with a sell rating, fourteen have given a hold rating and nine have issued a buy rating to the company. Cerner has an average rating of “Hold” and an average target price of $69.50.
Cerner Company Profile
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.